Pharmaceutics

Final Weeks to Register: 2 Day Pharmaceutical Regulatory Affairs in Asia Training Course - All Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (June 14-16, 2023) - ResearchAndMarkets.com

Retrieved on: 
Monday, April 10, 2023
Health, Pharmaceutical, Allen & Hanburys, Active ingredient, Pharma, Pharmaceutical formulation, London Organising Committee of the Olympic and Paralympic Games, University of Basel, University of Strathclyde, Head, DRA, Editorial board, Foreign, Commonwealth and Development Office, GSK plc, Biochemistry, Publication, Pharmaceutics, University of Manchester, Roche, Textbook, WHO, Novartis, Pharmaceutical industry, Pharmacy, Medtech, Chemistry

Prior to this, she worked at F. Hoffmann-La Roche in Switzerland where she gained several years' experience in industry basics and pre-clinical research.

Key Points: 
  • Prior to this, she worked at F. Hoffmann-La Roche in Switzerland where she gained several years' experience in industry basics and pre-clinical research.
  • Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.
  • He has also been director of two UK and Swiss registered pharmaceutical companies with specialised responsibility for international regulatory strategy.
  • Since 2012 he has been a member of the Editorial Board, Scrip Regulatory Affairs.

Pharmaceutical Regulatory Affairs in China Training Course (April 17-18, 2023) - ResearchAndMarkets.com

Retrieved on: 
Monday, March 13, 2023
Health, Pharmaceutical, University of Strathclyde, Novartis, Pharmaceutical formulation, Publication, WHO, Roche, DRA, Head, University of Basel, Biochemistry, Textbook, Editorial board, Foreign, Commonwealth and Development Office, London Organising Committee of the Olympic and Paralympic Games, Pharma, GSK plc, Active ingredient, Pharmaceutics, Allen & Hanburys, University of Manchester, Pharmaceutical industry, Chemistry, Pharmacy, Medtech

Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.

Key Points: 
  • Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.
  • Over 20 years were spent with Ciba-Geigy/CIBA/Novartis in all aspects of regulatory affairs including head of a group company DRA in Canada and for many years as Head of Pharma International regulatory affairs.
  • He has also been director of two UK and Swiss registered pharmaceutical companies with specialised responsibility for international regulatory strategy.
  • He is published, and his publications include a textbook on International Pharmaceutical Registration, Active Pharmaceutical Ingredients and as Swiss correspondent to the Regulatory Affairs Journals Pharma and Medtech.

2 Day Pharmaceutical Regulatory Affairs in China Training Course: Maintain a Successful Pharmaceutical Marketing Authorisation in PRC, including Hong Kong, Macau and Taiwan (April 17-18, 2023)

Retrieved on: 
Saturday, March 11, 2023
WHO, Pharma, DRA, Head, University of Strathclyde, Active ingredient, GSK plc, Editorial board, Foreign, Commonwealth and Development Office, Allen & Hanburys, Textbook, University of Basel, Pharmaceutical formulation, Pharmaceutics, London Organising Committee of the Olympic and Paralympic Games, Biochemistry, Roche, Novartis, University of Manchester, Publication, Pharmaceutical industry, Chemistry, Pharmacy, Medtech

Prior to this, she worked at F. Hoffmann-La Roche in Switzerland where she gained several years' experience in industry basics and pre-clinical research.

Key Points: 
  • Prior to this, she worked at F. Hoffmann-La Roche in Switzerland where she gained several years' experience in industry basics and pre-clinical research.
  • Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.
  • He has also been director of two UK and Swiss registered pharmaceutical companies with specialised responsibility for international regulatory strategy.
  • Since 2012 he has been a member of the Editorial Board, Scrip Regulatory Affairs.

Asia Pharmaceutical Regulatory Affairs Training Course: Opportunities and Challenges to those Wishing to Work in the Region (October 11-13, 2023)

Retrieved on: 
Wednesday, March 1, 2023
Pharmaceutics, Allen & Hanburys, Active ingredient, GSK plc, Foreign, Commonwealth and Development Office, Roche, DRA, University of Basel, Publication, Pharma, Head, WHO, London Organising Committee of the Olympic and Paralympic Games, Pharmaceutical formulation, University of Strathclyde, University of Manchester, Textbook, Biochemistry, Editorial board, Novartis, Pharmaceutical industry, Medtech, Pharmacy, Chemistry

Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.

Key Points: 
  • Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.
  • He has also been director of two UK and Swiss registered pharmaceutical companies with specialised responsibility for international regulatory strategy.
  • He is published, and his publications include a textbook on International Pharmaceutical Registration, Active Pharmaceutical Ingredients and as Swiss correspondent to the Regulatory Affairs Journals Pharma and Medtech.
  • Since 2012 he has been a member of the Editorial Board, Scrip Regulatory Affairs.

Asia Pharmaceutical Regulatory Affairs Training Course: Opportunities and Challenges to those Wishing to Work in the Region (October 11-13, 2023) - ResearchAndMarkets.com

Retrieved on: 
Friday, February 24, 2023
Pharmaceutical, Legal, Professional Services, Health, Pharmaceutics, Allen & Hanburys, Active ingredient, GSK plc, Foreign, Commonwealth and Development Office, Roche, DRA, University of Basel, Publication, Pharma, Head, WHO, London Organising Committee of the Olympic and Paralympic Games, Pharmaceutical formulation, University of Strathclyde, University of Manchester, Textbook, Biochemistry, Editorial board, Novartis, Pharmaceutical industry, Medtech, Pharmacy, Chemistry

Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.

Key Points: 
  • Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs.
  • He has also been director of two UK and Swiss registered pharmaceutical companies with specialised responsibility for international regulatory strategy.
  • He is published, and his publications include a textbook on International Pharmaceutical Registration, Active Pharmaceutical Ingredients and as Swiss correspondent to the Regulatory Affairs Journals Pharma and Medtech.
  • Since 2012 he has been a member of the Editorial Board, Scrip Regulatory Affairs.

Mahmoud Elhussini Combines His Experience as a Business Owner, Professor, and Corporate America Manager to Launch The Growth Coach of Allentown-Somerville

Retrieved on: 
Wednesday, February 8, 2023
MBA, DBA, Pharmaceutics, Fundamental series, NBC, John Paul II Center for Interreligious Dialogue, Entrepreneur (magazine), Pembrokeshire Action To Combat Hardship, Teaching, International Coaching Federation, CBS, S P Jain School of Global Management, Organization, Growth, Student, Peace, Marketing, Small business, Education, Strategy, FOX, USA Today, MS, International business, Music, Sales, Tutoring, Ethics, Bond, Biology

ALLENTOWN, Pa., Feb. 8, 2023 /PRNewswire-PRWeb/ -- Mahmoud "Moe" Elhussini owns a small business, has a background in corporate America, and has been teaching at the university level for almost ten years. Now he's excited to put that wide range of experience to work as the owner of his own business and sales coaching company – The Growth Coach of Allentown-Somerville.

Key Points: 
  • ALLENTOWN, Pa., Feb. 8, 2023 /PRNewswire-PRWeb/ -- Mahmoud "Moe" Elhussini owns a small business, has a background in corporate America, and has been teaching at the university level for almost ten years.
  • Now he's excited to put that wide range of experience to work as the owner of his own business and sales coaching company – The Growth Coach of Allentown-Somerville .
  • Opening The Growth Coach allows me to put my experience in corporate America.
  • For more information about how The Growth Coach of Allentown-Somerville, call 484-554-7415, email [email protected] or visit https://www.thegrowthcoach.com/allentown-somerville .

Copan Diagnostics Announces Leadership Change

Retrieved on: 
Thursday, February 2, 2023
Artificial intelligence, Health care, Pharmaceutics, Commercial, Pleasure, University of Milan, Marketing, Microbiology, Patient, University, Medical Affairs Bureau, Merck, Sadness, Partnership, Collection, Management, Chemistry

CARLSBAD, Calif., Feb. 2, 2023 /PRNewswire/ -- COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics' board of directors effective from January 9th, 2023.

Key Points: 
  • CARLSBAD, Calif., Feb. 2, 2023 /PRNewswire/ -- COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics' board of directors effective from January 9th, 2023.
  • It has been a privilege to serve as COPAN Diagnostics CEO and member of the board for almost three decades.
  • "It is with a mix of sadness and gratitude that we communicate this change in leadership.
  • "It's an honor for me to join COPAN Diagnostics and be part of COPAN.

Copan Diagnostics Announces Leadership Change

Retrieved on: 
Thursday, February 2, 2023
Artificial intelligence, Health care, Pharmaceutics, Commercial, Pleasure, University of Milan, Marketing, Microbiology, Patient, University, Medical Affairs Bureau, Merck, Sadness, Partnership, Collection, Management, Chemistry

CARLSBAD, Calif., Feb. 2, 2023 /PRNewswire/ -- COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics' board of directors effective from January 9th, 2023.

Key Points: 
  • CARLSBAD, Calif., Feb. 2, 2023 /PRNewswire/ -- COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics' board of directors effective from January 9th, 2023.
  • It has been a privilege to serve as COPAN Diagnostics CEO and member of the board for almost three decades.
  • "It is with a mix of sadness and gratitude that we communicate this change in leadership.
  • "It's an honor for me to join COPAN Diagnostics and be part of COPAN.

Carver Biosciences Announces Appointment of Three Members to its Scientific Advisory Board

Retrieved on: 
Tuesday, January 17, 2023
Biotechnology, Technology, Other Health, Health, General Health, Other Science, Research, Infectious Diseases, Nanotechnology, Genetics, Science, Infection, Severe acute respiratory syndrome coronavirus 2, Transdermal, UCPH Department of Biology, Editorial board, University of Washington Department of Bioengineering, Hepatitis B, NIH, United States Air Force Scientific Advisory Board, CRISPR, Associate, ERC, University, CRS, Internal medicine, Stanford University, Engineer, Degenerative disease, Chair, Pharmaceutics, RNA, Molecular Pharmaceutics, New York Genome Center, Scientist, Ludwig Maximilian University of Munich, Doctor of Philosophy, SNF, MIT, Nervous system, Physiology, BS, Y combinator, Computational linguistics, SAB, MS, PRDS, Drug resistance, JCR, Drug delivery, MIT Department of Brain and Cognitive Sciences, Cognitive science, Medical device, Pharmaceutical industry, Brain, Biology, Carver, List of life sciences, Neuroscience, New York University

Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).

Key Points: 
  • Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).
  • Cameron Myhrvold Ph.D., co-founder of Carver will serve as the chairman of the SAB.
  • Additional appointments include Uri Lopatin, M.D., Olivia Merkel, Ph.D., and Neville Sanjana, Ph.D.
    “I am thrilled to have Dr. Lopatin, Dr. Merkel and Dr. Sanjana join our advisory board,” said Dr. Walter Strapps, co-founder and CEO of Carver.
  • Dr. Sanjana holds a PhD in Brain and Cognitive Sciences from MIT, a BS in Symbolic Systems and a BA in English from Stanford University.

Xtalks Announces its Life Science Webinar Calendar for January 2023

Retrieved on: 
Wednesday, January 4, 2023
Molecule, Small molecule, Translation studies, Patient, Clinical trial, Drug discovery, Treatment, Future, Health, Evaluation, Drug development, Success, Inflammation, Food, Drug, Curate, Research, Pharmaceutics, Artificial intelligence, Pharmaceutical industry, XTalk

TORONTO, Jan. 4, 2023 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Key Points: 
  • See the Future Today
    Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.
  • Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)
  • Xtalks helps Life Science professionals stay current with industry developments, trends and regulations.
  • Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.